About me

Address: New York: One Bryant Park, Bank of America Tower, New York, NY 10036-6745

Areas of Focus: Intellectual Property; Patent Litigation; Litigation Finance; Trade Secret Litigation; Strategic IP Counseling; Complex Commercial Litigation; ITC Section 337 Investigations; Trademark, Copyright & Media Litigation; Government Contracts: Claims, Disputes & Litigation; IP Transactions; Emerging Technologies; Government Contracts Investigations

Biography:
Michael is a Chambers USA -ranked lead trial lawyer with significant victories at virtually every stage of litigation. With a global practice, Michael is a full-service strategic advisor for prominent life sciences and high-tech companies. Building upon long-term relationships of trust, Michael is called upon to take the lead on business-critical matters involving IP and related complex commercial disputes.
Michael proactively evaluates and addresses patent infringement and trade secret claims in the context of his clients’ market position and business goals. Working closely with in-house attorneys and executives, he wields his substantial skill as a strategist to manage complex cases to successful business resolutions or trial wins.
Michael has significant experience in all aspects of intellectual property litigation, including successes in district courts across the country, the International Trade Commission (ITC), the Patent Trial and Appeals Board (PTAB) and numerous alternative dispute resolution forums.
Michael is recognized by Chambers USA as a leading practitioner in Intellectual Property: Patent–New York, praised for being “thoughtful, responsive, and meticulously detailed in his analysis.” Additionally, Michael is a two-time Client Service All-Star, as awarded by BTI Consulting Group, honoring lawyers who provide exceptional levels of client service, as identified by their clients.
Alongside Akin’s market-leading investment funds, special situations, private credit and finance teams, Michael advises operating companies, funders, lenders, insurers and other investors on issues related to active and potential litigation assets. Whether in connection with large defense matters on behalf of operating companies or in connection with funding and investment decision making, Michael wields his knowledge of intellectual property law and the litigation finance ecosystem to drive successful outcomes for his clients. Michael sits alongside partners in Akin’s London and Hong Kong offices to support the firm’s worldwide, cross-practice collaboration on litigation assets.
Michael serves on Akin’s Executive Hiring Committee and the New York Opportunity & Inclusion Council. Michael previously served on the firm’s Partnership Admissions Committee for two consecutive three-year terms.

Representative Work:
- Represents Catalyst Orthoscience Inc. in a patent infringement case brought by Shoulder Innovations, Inc. in the District of Delaware. The plaintiff alleges infringement by Catalyst of claims from two patents directed to components used in certain reverse shoulder implant systems. Catalyst asserts counterclaims for infringement by Shoulder of patent claims directed to specialized offset reamers used in connection with shoulder implants. The parties are in the midst of discovery.
- Represents Solventum Corporation (formerly 3M HealthCare) in a patent infringement case brought by Wound Healing Technologies Corp. in the Western District of Texas. The plaintiff asserts that certain Solventum negative pressure therapy systems infringe one or more claims of its patent directed to wound dressings. The case is in its early stages.
- Represents Boston Scientific in post-trial and appellate proceedings relating to patent infringement claims brought by the Board of Regents of the University of Texas System and TissueGen Inc. The claims at issue are directed to biodegradable fiber implants with immiscible phases.
- Represents Signature Plumbing Specialties in a patent infringement case brought by Kohler Inc. in the Southern District of New York. Kohler originally asserted seven design patents and alleged infringement by multiple Signature products sold well before Kohler’s priority dates. Kohler later added claims for various business torts. The Court granted Signature’s motion to dismiss Kohler’s business tort claims and all but three remaining design patent claims. The Court then bifurcated and stayed Kohler’s affirmative allegations pending the completion of expedited discovery and summary judgment directed solely to Signature’s invalidity defenses.
- Represented a global technology company as a respondent in two, related investigations before the ITC. Each investigation involved the assertion of multiple patents against, inter alia , memory modules manufactured by our client. The matter settled favorably for our client.
- Represented Boston Scientific successfully in a series of multi-front patent and trade secret litigations against Nevro Corp. relating to spinal cord stimulation technology in the district of Delaware. The cases involved affirmative patent and trade secret claims asserted by Boston Scientific, counterclaims for patent infringement asserted by Nevro and parallel petitions for inter partes review (IPR) in both directions before the PTAB. The court scheduled trials for October 2021, January 2023 and October 2023. The jury in the 2021 trial returned a verdict finding Nevro liable for willful patent infringement and awarding Boston Scientific $20 million in damages. The case settled favorably in August 2022, prior to the next-scheduled trials.
- Represented Boston Scientific successfully in connection with PTAB proceedings brought by Micro-Tech (Nanjing) Co. Ltd. and Micro-Tech Endoscopy USA Inc. Micro-Tech petitioned the PTAB to initiate IPR proceedings over 15 Boston Scientific patent claims directed to hemostatic clips. After Boston Scientific submitted its Patent Owner Preliminary Response, the PTAB denied institution of review for all challenged claims, giving Boston Scientific a complete victory.

Credentials:
Education: J.D., Fordham University School of Law, 2001; B.A., University of Pennsylvania, 1998
Bar Admissions: New York, 2002
Court Admissions: U.S.D.C., Eastern District of New York; U.S.D.C., Southern District of New York; U.S.C.A., Federal Circuit

Recognitions:
- Chambers USA , Leading Practitioner in Intellectual Property: Patent–New York, 2022-2026; Described as a “strong, talented partner who presents arguments really well.”
- The Legal 500 US , Patents: Litigation (Full Coverage), 2021–2025.
- Managing IP , IP Stars – Patent Star, 2023-2025.
- LMG Life Sciences , Leading Life Sciences Lawyer, 2021; Life Sciences Star, 2022.
- IAM Patent 1000—The World’s Leading Patent Professionals , Leading Private Patent Litigator in New York, 2021, 2024-2026.
- IAM Strategy 300 — The World’s Leading IP Strategists 2025.
- BTI Consulting Group , Client Service All-Star, 2020, 2024.
- Akin, New York Office, Partner Recognition Award, 2018.
- Immigration Equality, Safe Haven Award, Recognition for Excellence in Pro Bono Representation, 2013.

Affiliations:
- Advisory Board Member, The Johns Lyng Group USA.
- Vice-Chair, Community Foundation Board, Northern Westchester Hospital.

Insights:
- Akin Attorneys and Practices Recognized in 2026 IP Stars  (August 3, 2026): https://www.akingump.com/en/insights/awards-and-accolades/akin-attorneys-and-practices-recognized-in-2026-ip-stars
- 11 Akin Lawyers Named to 2026 IAM Patent 1000  (June 3, 2026): https://www.akingump.com/en/insights/awards-and-accolades/11-akin-lawyers-named-to-2026-iam-patent-1000
- Chambers USA 2026 Recognizes Akin Lawyers and Practices  (June 4, 2026): https://www.akingump.com/en/insights/awards-and-accolades/chambers-usa-2026-recognizes-akin-lawyers-and-practices
- The American Lawyer Features Akin Intellectual Property Team Jury Trial Win in Litigator of the Week (January 23, 2026 ): https://www.akingump.com/en/insights/awards-and-accolades/the-american-lawyer-features-akin-intellectual-property-team-jury-trial-win-in-litigator-of-the-week
- Akin Intelligence Newsletter - August/September 2025  (October 24, 2025): https://www.akingump.com/en/insights/newsletters/akin-intelligence-newsletter-august-september-2025
- Akin Lawyers and Practices Recognized in 2025 IP Stars (October 1, 2025): https://www.akingump.com/en/insights/awards-and-accolades/akin-lawyers-and-practices-recognized-in-2025-ip-stars
- Michael Kahn and David Vondle Recognized in 2025 IAM Strategy 300  (August 25, 2025): https://www.akingump.com/en/insights/awards-and-accolades/michael-kahn-and-david-vondle-recognized-in-2025-iam-strategy-300
- Akin Intelligence - July 2025 (August 22, 2025): https://www.akingump.com/en/insights/newsletters/akin-intelligence-July-2025
- Akin Intelligence - June 2025 (July 7, 2025): https://www.akingump.com/en/insights/newsletters/akin-intelligence-june-2025
- Akin Intelligence - May 2025 (June 27, 2025): https://www.akingump.com/en/insights/newsletters/akin-intelligence-may-2025
- Akin Secures Top Rankings in The Legal 500 US 2025  (June 12, 2025): https://www.akingump.com/en/insights/awards-and-accolades/akin-secures-top-rankings-in-the-legal-500-us-2025
- Chambers USA 2025 Recognizes Akin Lawyers and Practices (June 5, 2025): https://www.akingump.com/en/insights/awards-and-accolades/chambers-usa-2025-recognizes-akin-lawyers-and-practices